Vaxcyte, Inc. (PCVX)
60.69
+0.87
(+1.45%)
USD |
NASDAQ |
Apr 07, 16:00
60.71
+0.02
(+0.03%)
After-Hours: 20:00
Vaxcyte EPS Diluted (Quarterly) : -1.881 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Cytokinetics, Inc. | -1.495 |
| Syndax Pharmaceuticals, Inc. | -0.7786 |
| Rhythm Pharmaceuticals, Inc. | -0.7302 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -246.51M |
| Total Expenses (Quarterly) | 246.51M |
| Enterprise Value | 7.291B |
| Earnings Yield | -9.26% |
| Normalized Earnings Yield | -9.263 |